Melanoma Institute Australia launches free e-learning education portal
20 June 2018
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment to ensure best practice and equity of care for melanoma patients around the country.
The new online education portal is designed for healthcare professionals including specialists, dermatologists, GPs and nurses. It provides accredited videos and comprehensive training modules relating to the rapidly changing melanoma diagnostic and treatment landscape.
Melanoma Institute Australia Conjoint Medical Director, Professor Georgina Long, said the e-learning portal would ultimately improve melanoma patient care and outcomes within Australia and internationally.
“Our new education portal will be practice changing for healthcare professionals, particularly those who do not normally specialise in diagnosing and treating melanoma,” Professor Long said. “It gives them access to training modules covering best practice in diagnosing and managing melanoma, as well as translating world-leading research into clinical knowledge to ultimately improve patient outcomes.”
MIA Conjoint Medical Director, Professor Richard Scolyer, added, “We’re excited to bring together the collective expertise from MIA, which is the world’s largest research and treatment institute with a single focus on melanoma. The portal will ensure healthcare professionals have free 24/7 access to the latest advances in melanoma clinical practice and research, regardless of where they are located. This will benefit melanoma patients all over the world, and ultimately, save lives.” he said.
New content will be added to the site regularly and registered healthcare professionals can earn accreditation points. Healthcare professionals are invited to access the free site by registering at melanomaeducation.org.au
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.